Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Pharmacogenomics J ; 18(1): 35-42, 2018 01.
Artigo em Inglês | MEDLINE | ID: mdl-27845419

RESUMO

Neutropenia is a common dose-limiting toxicity associated with irinotecan treatment. Although UGT1A1 variants have been associated with neutropenia, a fraction of neutropenia risk remains unaccounted for. To identify additional genetic markers contributing to variability in irinotecan pharmacokinetics and neutropenia, a regression analysis was performed in 78 irinotecan-treated patients to analyze comprehensively three hepatic efflux transporter genes (ABCB1, ABCC1 and ABCG2). rs6498588 (ABCC1) and rs12720066 (ABCB1) were associated with increased SN-38 exposure, and rs17501331 (ABCC1) and rs12720066 were associated with lower absolute neutrophil count nadir. rs6498588 and a variant in high linkage disequilibrium are located in transcriptionally active regions or are predicted to alter transcription factor binding sites. While enhancer activity was not evident in vitro for genomic regions containing these single-nucleotide polymorphisms, rs6498588 was significantly associated with ABCC1 expression in human liver. These results suggest that genetic variation in ABCC1 and ABCB1 may contribute to irinotecan-induced neutropenia by altering expression of transporters involved in irinotecan metabolite disposition.


Assuntos
Transportadores de Cassetes de Ligação de ATP/genética , Irinotecano/farmacocinética , Neutropenia/genética , Neutropenia/metabolismo , Polimorfismo de Nucleotídeo Único/genética , Adulto , Idoso , Feminino , Genótipo , Humanos , Masculino , Proteínas de Membrana Transportadoras/genética , Pessoa de Meia-Idade , Proteínas de Neoplasias/genética , Ativação Transcricional/genética
2.
Vet Comp Oncol ; 11(1): 30-50, 2013 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-22236332

RESUMO

Molecular characterization of tumour cell lines is increasingly regarded as a prerequisite for defining their validity as models of in vivo neoplasia. We present the first comprehensive catalogue of genomic and transcriptional characteristics of five widely used canine lymphoid tumour cell lines. High-resolution microarray-based comparative genomic hybridization defined their unique profiles of genomic DNA copy number imbalance. Multicolour fluorescence in situ hybridization identified aberrant gains of MYC, KIT and FLT3 and deletions of PTEN and CDKN2 in individual cell lines, and also revealed examples of extensive structural chromosome reorganization. Gene expression profiling and RT-PCR analyses defined the relationship between genomic imbalance and transcriptional dysregulation in each cell line, clarifying their relevance as models of discrete functional pathways with biological and therapeutic significance. In combination, these data provide an extensive resource of molecular data for directing the appropriate use of these cell lines as tools for studying canine lymphoid neoplasia.


Assuntos
Doenças do Cão/metabolismo , Regulação Neoplásica da Expressão Gênica/fisiologia , Linfoma/metabolismo , Animais , Linhagem Celular Tumoral , DNA/genética , DNA/metabolismo , Cães , Citometria de Fluxo , Cariótipo , Proteínas de Neoplasias/genética , Proteínas de Neoplasias/metabolismo , RNA/genética , RNA/metabolismo , Reação em Cadeia da Polimerase em Tempo Real/veterinária , Transcriptoma
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA